jb-trust-fund

JB Holdings through its Subsidiary JB Trust Fund is proud to have partnered with Zion Medical BV, which is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of AIDS, Cancer and other immune deficiency diseases in Israel.
Zion Medical is an Israeli based biopharmaceutical company engaged in the development and commercialization of products for the treatment of AIDS, Cancer and other immune deficiency diseases. The experimental drug developed by the company, is called Gammora and it uses peptides to eradicate HIV infected human cultured cells and cancer cells. The research was conducted at the Hebrew University and Kaplan HIV Medical Centre in Israel.

For further information watch this video

The breakthrough research conducted by Zion Medical has led to the successful discovery of AIDS and Cancer curing products based on peptides derived from HIV and targeted lenti virus particals.

About the Treatment

Gammora contains peptides derived from HIV virus that promote infected cells into self-induced death (apoptosis) in few steps:
Harmless Lenti-Virus-Particles, such used in gene therapy, are being developed to target only HIV infected cells or cancer cells. Harmless DNA loaded Lenti-virus particles such as used. This overloading of additional DNA disrupts the infected cells chromosomes functionality, forcing the infected cells to commit self-induced death (apoptosis). Apoptosis is a natural biological process and its remains are consumed or removed as a normal body process. This process will thus cure both illnesses by killing the infected cells without harm to normal cells

Key Achievements

  • Demonstrated the effectiveness of the peptides to eradicate HIV infected human cultured cells – conducted in Israel (Hebrew University)
  • Demonstrated the activity of the peptide on HIV infected mice cultured cells – conducted in in N.Y. (Volsky)
  • Demonstrated the activity of the peptides when using lenti-virus particles as the vehicle to introduce the “killing genes” – conducted in Israel (Smart Assay Labs- Rehovot)
  • Demonstrated the effectiveness of the peptides on blood drown from HIV patients – conducted in Israel (Kaplan Medical Center, Rehovot)
  • Demonstrated the activity of the peptides together with lenti-virus particles in lung, pancreatic, colon and breast cancer cells – conducted in Israel (Tel Aviv Sourasky Medical Center and Kaplan Medical Center, Rehovot
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search